Hologic Inc. (HOLX)

AI Score

Unlock

58.83

0.98 (1.69%)

At close: Apr 14, 2025, 3:38 PM

1.69% (1D)

Bid	58.82
Market Cap	13.2B
Revenue (ttm)	4.04B
Net Income (ttm)	744M
EPS (ttm)	3.16
PE Ratio (ttm)	18.62
Forward PE	15.48
Analyst	Hold

Ask	58.98
Volume	3,116,370
Avg. Volume (20D)	2,765,893
Open	58.28
Previous Close	57.85
Day's Range	57.67 - 58.88
52-Week Range	56.27 - 84.67
Beta	0.83

About HOLX

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima vi...

Sector Healthcare

IPO Date Mar 1, 1990

Employees 7,063

Stock Exchange NASDAQ

Ticker Symbol HOLX

Website https://www.hologic.com

Full Company Profile

Analyst Forecast

According to 14 analyst ratings, the average rating for HOLX stock is "Hold." The 12-month stock price forecast is $85, which is an increase of 44.48% from the latest price.

Stock Forecasts

Next Earnings Release

Hologic Inc. is scheduled to release its earnings on May 1, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

2 months ago

-10.1%

Hologic shares are trading lower after the company... Unlock content with Pro Subscription

5 months ago

-5.88%

Hologic shares are trading lower. The company reported Q4 financial results.

News

2 days ago · zacks.com

Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know

Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

1 week ago · zacks.com

Hologic (HOLX) Advances While Market Declines: Some Information for Investors

Hologic (HOLX) concluded the recent trading session at $61.27, signifying a +0.67% move from its prior day's close.

6 days ago · zacks.com

Hologic Brings in New Leadership: A Signal to Stay Put With the Stock?

HOLX's diagnostics strength, robust international potential and new board addition support its "Hold" case. Yet, ongoing global uncertainties remain a drag.

1 week ago · businesswire.com

Wayde McMillan Elected to Hologic Board of Directors

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #governance--Wayde McMillan Elected to Hologic Board of Directors.

1 week ago · businesswire.com

Hologic to Announce Financial Results for the Second Quarter of Fiscal 2025 on Thursday, May 1, 2025

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #earnings--Hologic to Announce Financial Results for the Second Quarter of Fiscal 2025 on Thursday, May 1, 2025.